Related Experiment Video
Updated: Jan 23, 2026

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Natural Terpenoids as Neuroinflammatory Inhibitors in LPS-stimulated BV-2 Microglia
Yuanzhen Xu1, Hongbo Wei1, Jinming Gao1
1Shaanxi Key Laboratory of Natural Products and Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, China.
Abstract:
Neuroinflammation is a typical feature of many neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Microglia, the resident immune cells of the brain, readily become activated in response to an infection or an injury. Uncontrolled and overactivated microglia can release pro-inflammatory and cytotoxic factors and are the major culprits in neuroinflammation. Hence, research on novel neuroinflammatory inhibitors is of paramount importance for the treatment of neurodegenerative diseases. Bacterial lipopolysaccharide, widely used in the studies of brain inflammation, initiates several major cellular activities that critically contribute to the pathogenesis of neuroinflammation. This review will highlight the progress on terpenoids, an important and structurally diverse group of natural compounds, as neuroinflammatory inhibitors in lipopolysaccharidestimulated BV-2 microglial cells over the last 20 years.
Insights
Terpenoids show promise in inhibiting neuroinflammation, a key factor in diseases like Alzheimer's. This review covers research on terpenoids as potential treatments for lipopolysaccharide-induced microglial activation over the past two decades.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Neuroinflammation, driven by activated microglia, is central to neurodegenerative diseases such as Alzheimer's and Parkinson's.
- Overactivated microglia release harmful factors, exacerbating neuronal damage.
- Bacterial lipopolysaccharide (LPS) is a common trigger used to study brain inflammation and its pathological mechanisms.
Purpose of the Study:
- To review the progress of terpenoids as inhibitors of neuroinflammation.
- To focus on studies involving LPS-stimulated BV-2 microglial cells over the last 20 years.
Main Methods:
- Literature review of studies published in the last 20 years.
- Focus on research investigating terpenoids' effects on LPS-induced microglial activation.
- Analysis of terpenoids' mechanisms in modulating inflammatory responses in BV-2 cells.
Main Results:
- Terpenoids represent a diverse group of natural compounds with demonstrated neuroinflammatory inhibitory potential.
- Specific terpenoids have shown efficacy in reducing inflammatory markers in LPS-stimulated microglial models.
- The last two decades have seen significant research into terpenoids for neuroinflammation.
Conclusions:
- Terpenoids are promising candidates for developing novel neuroinflammatory inhibitors.
- Further research is warranted to explore the therapeutic potential of terpenoids for neurodegenerative diseases.
- Targeting microglial activation with compounds like terpenoids could offer new treatment strategies.
More Related Videos
06:43Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
06:12Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
What is Natural Selection?
Nature and Nurture
Chirality in Nature
The Wave Nature of Light
Limits to Natural Selection